Expanding the histological spectrum of salivary gland neoplasms with HMGA2::WIF1 fusion emphasising their malignant potential: a report of eight cases
Histopathology · 2024-01 · 84 (2) · 387-398
DOI: 10.1111/his.15074 ↗Kurz gefasst
Fallbericht in der Zeitschrift Histopathology, online erschienen am 18.10.2023. Verfasst von Nora Katabi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Adenoma, Pleomorphic, Carcinoma, Salivary Gland Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Aims
Recently, HMGA2::WIF1 fusion has been reported in pleomorphic adenoma (PAs) originating from the parotid gland with a characteristic canalicular adenoma (CAA)‐like pattern. However, it is unclear whether HMGA2::WIF1 fusion may occur in salivary gland carcinoma or tumours originating from the minor salivary glands. We herein conducted a detailed clinicopathological review of eight salivary gland tumours harbouring HMGA2::WIF1 fusions. Methods and results The reviewed diagnoses of salivary gland neoplasms with HMGA2::WIF1 fusion were PA ( n = four), myoepithelioma ( n = one), myoepithelial carcinoma ex PA ( n = two) and high‐grade carcinoma with basaloid features ( n = one). Two tumours originated from the minor salivary glands. Six tumours (80%) contained areas reminiscent of CAA characterised by interconnected trabeculae/canaliculi of monotonous oncocytic or cuboidal tumour cells associated with a hypocellular, hyalinised to myxoid stroma. Areas typical of PA were seen in four (50%) cases. All tumours showed diffuse S100 and CK7 immunopositivity. Adverse events were detected in two cases, including local recurrence in a patient with PA, and local and distant recurrences and disease‐related death in a patient with a high‐grade carcinoma of the minor salivary gland of the buccal space, showing tumour necrosis and perineural invasion.
Conclusion
Salivary gland neoplasms with HMGA2::WIF1 fusion are predominantly characterised by CAA/striated duct adenoma‐like histology and a S100+/CK7+ immunoprofile. These tumours are not always benign, as among all reported cases approximately 20% showed malignancy (six of 28) and adverse outcome (three of 15), including recurrence, distant metastasis and disease‐specific mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Pathology, University Health Network, Toronto, ON, Canada.
- Department of Pathology and Laboratory Medicine, Sinai Health System, Toronto, ON, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Purvil Sukhadia, Bin Xu
Förderung
- NCI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Katabi, N., Sukhadia, P., DiNapoli, S. E., Weinreb, I., Hahn, E., Ghossein, R., & Xu, B. (2024). Expanding the histological spectrum of salivary gland neoplasms with HMGA2::WIF1 fusion emphasising their malignant potential: a report of eight cases. Histopathology, 84(2), 387-398. https://doi.org/10.1111/his.15074
Vancouver
Katabi N, Sukhadia P, DiNapoli SE, Weinreb I, Hahn E, Ghossein R, et al. Expanding the histological spectrum of salivary gland neoplasms with HMGA2::WIF1 fusion emphasising their malignant potential: a report of eight cases. Histopathology. 2024;84(2):387-398. doi:10.1111/his.15074
BibTeX
@article{Katabi2024,
author = {Katabi, Nora and Sukhadia, Purvil and DiNapoli, Sara E and Weinreb, Ilan and Hahn, Elan and Ghossein, Ronald and Xu, Bin},
title = {Expanding the histological spectrum of salivary gland neoplasms with HMGA2::WIF1 fusion emphasising their malignant potential: a report of eight cases},
journal = {Histopathology},
year = {2024},
volume = {84},
number = {2},
pages = {387--398},
doi = {10.1111/his.15074}
}
EUVIMED